Jenburkt Pharmaceuticals Balance Sheet Health
Financial Health criteria checks 6/6
Jenburkt Pharmaceuticals has a total shareholder equity of ₹1.3B and total debt of ₹2.6M, which brings its debt-to-equity ratio to 0.2%. Its total assets and total liabilities are ₹1.5B and ₹195.1M respectively. Jenburkt Pharmaceuticals's EBIT is ₹285.3M making its interest coverage ratio -7.4. It has cash and short-term investments of ₹556.9M.
Key information
0.2%
Debt to equity ratio
₹2.63m
Debt
Interest coverage ratio | -7.4x |
Cash | ₹556.90m |
Equity | ₹1.30b |
Total liabilities | ₹195.12m |
Total assets | ₹1.50b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 524731's short term assets (₹830.0M) exceed its short term liabilities (₹158.8M).
Long Term Liabilities: 524731's short term assets (₹830.0M) exceed its long term liabilities (₹36.3M).
Debt to Equity History and Analysis
Debt Level: 524731 has more cash than its total debt.
Reducing Debt: 524731's debt to equity ratio has reduced from 5% to 0.2% over the past 5 years.
Debt Coverage: 524731's debt is well covered by operating cash flow (5266.5%).
Interest Coverage: 524731 earns more interest than it pays, so coverage of interest payments is not a concern.